Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Time to load up LTG! Big deals with Apple, Microsoft and some crypto all coming soon!
Just look at the last 2 8K’s... they sold a small amount of shares and took a short term loan for a few 100 grand. It sounds like they just needed some lunch money before a huge government grants come in. I bet it was contingent on the FDAs pre-IND meeting outcome.
if we get news of fast track .35 easy...
PR out
ANAHEIM, CA , Jan. 26, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that it held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) on January 24, 2018 regarding the Company's naltrexone implant, BICX102. BICX102 is the Company's sustained release naltrexone implant for the treatment of opioid and alcohol use disorders.
The National Institute on Drug Abuse (NIDA) joined the meeting as observers, along with Brady Granier, CEO and Director of BioCorRx, and the Company’s regulatory experts and consultants. In the meeting, BioCorRx discussed the responses that were received prior to the meeting from the FDA in regard to the pre-IND package, which had been submitted last month. The package included information on BICX102, as well as the proposed development plan for commercialization. As a result of the meeting, the Company plans to move forward with the product as anticipated.
Brady Granier, President, CEO and Director of BioCorRx, stated, “We are pleased with the FDA’s responses to our development plan and appreciative of their time in the meeting. We look forward to providing a more thorough update as soon as we receive and review the meeting minutes from the FDA as to confirm all items verbally discussed. In the meantime, we will continue moving forward with our BICX102 plans.”
https://ir.biocorrx.com/news/detail/114
The IND package was submitted a while ago so i bet the FDA already has the recommended pathway to approval for BICX. IMO, today is the last day to buy shares at these prices and we get a PR tomorrow morning.
Neltrexone is approved, not the implant. The meeting is getting direction from the FDA on the roadmap for approval. The outcome of the meeting is very important and should give us an idea on timing.
it sounds like a tiny bit of cash to get them through a few weeks. IMO, they are expecting a big jump in share price and then they can raise money for FDA trials.
Anyone have an idea of the run up here the past month? Data coming?
.50 before the FDA meeting!
Does it make you want to load the boat?
Buprenorphine is addictive so that’s why naltrexone is much better.
Linda hooked up her friends with shares the last raise before the monster news hits.
Once the government grant money come through you will see much higher. That trip to the White House wasn’t for the tour.
BIG fish is just about reeled in. Mark this post.
No shot - .01+ next week before turkey day.
Just think if you bought those .005’s you would be up 80% right now ;)
last chance to get your shares sub-penny. I guarantee people will be paying .02 in the next couple weeks.
.008's are gone! .009's are up... This might be the last chance to buy sub-penny so get your shares.
This is only the beginning. Sit back and watch the run over .03 - the fix is in.....
Time to load up Willy! Your next cruise will be on a private yacht.
Big news coming today! Buckle up!
Buyout news will be coming very soon. Mark this post!
10K offer is usually a market maker now really showing how many shares are for sale.
Big buy out coming $1 minimum
10’s of million in grant money is coming. Get your shares while you can.
Smart money gobbled up those 12 millions shares the other day. BIG payday is coming - don’t miss the $$$BUS$$$
Sounds like most of the stocks on the OTC. I picked up a few more yesterday and the news is coming.....
The BIG fish is on the line and getting reeled in!
Dead money
I heard the deal was already done. PR Is going to drop real soon. You better get your shares. I loaded up Big.
million share trade at .006! I heard it's been a couple of big sellers the past few weeks and they are almost out of shares...
The whales are leading up right now. .03+ is right around the corner :)
Who is JS?
we just broke $4 - did I miss some news?
too bad you guys missed out on those .006's - you will be missing out on the .008's when we break .01 so you better load that dry powder.
Tons of gov grants for the opioid crisis and 28 million just for medication-assisted treatment (the Implant). It sounds like they will have the cash and no more dilution.
HHS announces over $70 million in grants to address the opioid crisis
Health and Human Services Secretary Tom Price, M.D., today announced the availability of over $70 million over multiple years to help communities and healthcare providers prevent opioid overdose deaths and provide treatment for opioid use disorder, of which $28 million will be dedicated for medication-assisted treatment (MAT).
“Putting an end to the opioid crisis ravaging our country is a top priority for President Trump and all of us at the Department of Health and Human Services,” said HHS Secretary Tom Price. “We are committed to bringing everything the federal government has to bear on this health crisis. Building partnerships and providing resources to state and local governments as well as non-government organizations are absolutely critical to this effort. The purpose of these grants is to empower the heroes in this fight—the men and women on the forefront of supporting prevention, treatment, and recovery initiatives in their communities.”
Opioid overdoses claimed more than 33,000 lives in 2015, but preventive actions, treatment for addiction, and proper response to overdoses can help. Money from two grant funding opportunities, recently authorized by the Comprehensive Addiction and Recovery Act (CARA), will expand access to lifesaving overdose reversal medications and train healthcare providers to refer patients to appropriate follow-up drug treatment; funds from a third grant funding opportunity will provide for medication-assisted treatment of opioid use disorders.
The announcement followed a separate award of $485 million in grants in April 2017—provided by the 21st Century Cures Act— to all 50 states, the District of Columbia, four U.S. territories, and the free associated states of Palau and Micronesia for opioid abuse prevention, treatment, and recovery. Administered through the Substance Abuse and Mental Health Services Administration (SAMHSA), these funds will be made available through the following three grants:
Medication-Assisted Treatment and Prescription Drugs Opioid Addiction: Up to $28 million to 5 grantees to increase access of medication-assisted treatment for opioid use disorder. Medication-assisted treatment combines behavioral therapy and FDA-approved medication.
First Responders: Up to $41.7 million over 4 years available to approximately 30 grantees to train and provide resources for first responders and members of other key community sectors on carrying and administering an FDA approved product for emergency treatment of known or suspected opioid overdose.
Improving Access to Overdose Treatment: Up to $1 million over 5 years to one grantee to expand availability to overdose reversal medications in healthcare settings and to establish protocols to connect patients who have experienced a drug overdose with appropriate treatment.
“The grants we announce today clearly demonstrate our efforts to meet the opioid crisis with every tool at our disposal,” said SAMHSA Acting Deputy Assistant Secretary Kana Enomoto. “The evidence-based training, medication, and behavioral therapies provided here will save lives and help people with addictions start a path toward reaching their potential.”
Additionally, on May 4, SAMHSA released two other Comprehensive Addiction and Recovery Act-related funding opportunities. These funding opportunities will be open through July 3, 2017:
State Pilot Grant Program for Treatment for Pregnant and Postpartum Women: Up to $3.3 million to support a range of family-based services for pregnant and postpartum women with substance use disorder.
Building Communities of Recovery: Up to $2.6 million to mobilize resources within and outside of the recovery community to increase the prevalence and quality of long-term recovery support from substance abuse and addiction.
The Trump Administration and Health and Human Services Secretary Tom Price have identified the opioid crisis as one of the top priorities for improving the health of the American people. HHS has outlined five specific strategies to combat the ongoing opioid crisis: strengthening public health surveillance, advancing the practice of pain management, improving access to treatment and recovery services, targeting availability and distribution of overdose-reversing drugs, and supporting cutting-edge research. With the completion of the fiscal year 2017 spending package passed by Congress, HHS moved quickly to announce these funding opportunities which are critical to improving access to treatment and recovery services as well as targeting availability and distribution of overdose-reversing drugs.
https://www.hhs.gov/about/news/2017/05/31/hhs-announces-over-70-million-in-grants-to-address-the-opioid-crisis.html
We slowly run up with FDA updates. I don’t think we see a buyout until we have an FDA approved implant generating revenue. BICX ran to .30+ on air so it will happen again
.03 are coming LTV so time to load up. Last run from sub penny was to .10 so get ready.
Is the conference Linda is speaking at next week or this week?